Information Provided By: 
Fly News Breaks for November 6, 2018
BCPC
Nov 6, 2018 | 15:04 EDT
As previously reported, Pivotal Research analyst Timothy Ramey upgraded Balchem to Buy from Hold, stating that he has "long admired" the company's excellent growth and now he sees the shares at an attractive entry point. The company's balance sheet "remains a powerhouse" and Ramey would not be surprised by another deal for the company, which he calls "masterful at the tuck-in accretive deal." Ramey raised his price target on Balchem shares to $100 on the heels of the company's Q3 earnings beat.
News For BCPC From the Last 2 Days
There are no results for your query BCPC
